To develop therapies targeting fibroblasts & macrophages that will benefit patients suffering from fibrosis, cancer, infection and autoimmunity.
To uncover the foundational aspects of fibroblast & macrophage biology required to discover and actuate therapeutic targets.
Nature Reviews Immunology, 2023
Cancer Cell, 2022
Immunity, 2021